| Year |
Citation |
Score |
| 2019 |
Fiandalo MV, Gewirth DT, Mohler JL. Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer. Asian Journal of Urology. 6: 50-56. PMID 30775248 DOI: 10.1016/J.Ajur.2018.09.002 |
0.385 |
|
| 2018 |
Popova AV, Frasinyuk MS, Bondarenko SP, Zhang W, Xie Y, Martin ZM, Cai X, Fiandalo MV, Mohler JL, Liu C, Watt DS, Sviripa VM. Efficient Synthesis of Aurone Mannich Bases and Evaluation of their Antineoplastic Activity in PC-3 Prostate Cancer Cells. Chemicke Zvesti. 72: 2443-2456. PMID 36238867 DOI: 10.1007/s11696-018-0485-8 |
0.355 |
|
| 2018 |
Fiandalo MV, Stocking JJ, Pop EA, Wilton JH, Mantione KM, Li Y, Attwood KM, Azabdaftari G, Wu Y, Watt DS, Wilson EM, Mohler JL. Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade. Oncotarget. 9: 11227-11242. PMID 29541409 DOI: 10.18632/oncotarget.24107 |
0.318 |
|
| 2017 |
Frasinyuk MS, Zhang W, Wyrebek P, Yu T, Xu X, Sviripa VM, Bondarenko SP, Xie Y, Ngo HX, Morris AJ, Mohler JL, Fiandalo MV, Watt DS, Liu C. Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4). Organic & Biomolecular Chemistry. PMID 28868548 DOI: 10.1039/C7Ob01584D |
0.416 |
|
| 2016 |
Stocking JJ, Fiandalo MV, Pop EA, Wilton JH, Azabdaftari G, Mohler JL. Characterization of Prostate Cancer in a Functional Eunuch. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 1054-60. PMID 27587619 |
0.37 |
|
| 2014 |
Fiandalo MV, Wilton J, Mohler JL. Roles for the backdoor pathway of androgen metabolism in prostate cancer response to castration and drug treatment. International Journal of Biological Sciences. 10: 596-601. PMID 24948872 DOI: 10.7150/ijbs.8780 |
0.357 |
|
| 2013 |
Fiandalo MV, Kyprianou N. p27 Stands-up-to-cancer: UPS nuclear service stops. Endocrinology. 154: 3970-3. PMID 24141996 DOI: 10.1210/En.2013-1873 |
0.521 |
|
| 2013 |
Fiandalo MV, Wu W, Mohler JL. The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy. Current Drug Targets. 14: 420-40. PMID 23565755 DOI: 10.2174/1389450111314040004 |
0.436 |
|
| 2013 |
Fiandalo MV, Schwarze SR, Kyprianou N. Proteasomal regulation of caspase-8 in cancer cell apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 18: 766-76. PMID 23456622 DOI: 10.1007/S10495-013-0821-Y |
0.623 |
|
| 2012 |
Fiandalo MV, Kyprianou N. Caspase control: protagonists of cancer cell apoptosis. Experimental Oncology. 34: 165-75. PMID 23070001 |
0.642 |
|
| 2012 |
Fiandalo M, Schwarze S, Kyprianou N. Abstract 4969: Impact of proteasome inhibition of caspase-8 regulation in cancer Cancer Research. 72: 4969-4969. DOI: 10.1158/1538-7445.Am2012-4969 |
0.623 |
|
| 2012 |
Martin SK, Fiandalo MV, Kyprianou N. Androgen receptor signaling interactions control epithelial-mesenchymal transition (EMT) in prostate cancer progression Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 227-255. DOI: 10.1007/978-1-4614-6182-1_15 |
0.474 |
|
| 2011 |
Christian PA, Fiandalo MV, Schwarze SR. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH. Molecular Cancer. 10: 57. PMID 21586138 DOI: 10.1186/1476-4598-10-57 |
0.5 |
|
| Show low-probability matches. |